NSW KPIs
Additional information for NSW KPIs.
Before you start
If your health service is using Communicare ‘out of the box’ and has taken advantage of datasets provided by Communicare, only the codes highlighted here need to be considered.
Clinical items
This section identifies any local clinical items that may be evidence of procedures and other activity required for specific indicators.
Configuration is done at
.Performance indicator | For | Description |
---|---|---|
Smoking Cessation |
|
|
Immunisation Types | Influenza | Communicare supports the Generic Influenza AIR vaccine, with vaccine code GNFLU, and its equivalents described in Equivalent and partial equivalent vaccines table - GNFLU entry. For example, GNFLU, PANVAX, FLUVAX, and so on. |
Pertussis | The following export codes identify pertussis vaccines: ADCL, ADPO, BOOST or BOIPV. |
If you do not make Medicare claims, make sure that clinical items used to record care plans and health checks use the following system codes.
Qualifiers
This section identifies any local qualifiers that may be evidence of details required for specific indicators.
Configuration is done at
.Performance indicator | Code | Description |
---|---|---|
Smoking Cessation | BIP | Any clinical item that is evidence of ‘brief intervention’ should
have a qualifier that is either:
|
Smoking Status | SMO or SMP |
The central qualifiers are appropriately coded, but if a local variation is used the qualifier itself must be a reference qualifier with the system code SMO or SMP (if recorded during a pregnancy). Each reference must be coded in the following way:
|
Central pathology qualifiers | BPS, CHO, CHR, HDL, CVR-R05C, CVR-R05F, ACR, GFE, HBA, HBM, AUDITC, XHB, XHC, XCL, XGN, XSY, XHI | Only of interest if the health service has local equivalents:
|
Investigation Requests
This section identifies keywords that need to be attached to any of your investigation request terms to identify them as STI test requests.
Configuration is done at
.STI request terms
Infection | keyword |
---|---|
Hepatitis B | HepB |
HBV DNA Viral load test | HBV |
HCV RNA test | HVCRNA |
Chlamydia | CHLAMYDIA |
Gonorrhoea | GONORRHOEA |
Syphilis | SYPHILIS |
HIV | HIV |
Liver Function Tests
Liver Function Tests are determined from Pathology test requests that have a keyword of LFT.
Central and imported codes
This section refers to codes that are attached to ICPC2-Plus items, MIMS medications, incoming pathology results (LOINCs), and so on. Some labs use their own local codes to identify pathology results and use of LOINCs for text-based results is not consistent.
Database | Report | Description |
---|---|---|
MIMS | Smoking Cessation | Medications with an indication containing the text smok or nicotine are identified as smoking cessation treatments. For example, the drug Champix is included because it has an indication of Nicotine dependence. |
CVD Risk Treatment |
Medications with an indication of hyperlipidaemia, hypercholesterolaemia or hypertension are identified as smoking cessation treatments. For example, the drug Cleviprex is included because it has an indication of Hypertension. |
|
DAA Treatment | Recent prescriptions are identified by the following generic components: pegylated interferon, daclatasvir, sofosbuvir + ledipasvir, ribavirin, sofosbuvir, paritaprevir + ritonavir + ombitasvir + dasabuvir, paritaprevir + ritonavir + ombitasvir + dasabuvir + ribavirin. | |
LOINC | Incoming pathology results are identified by LOINCs (if supplied by the lab) for the specified STI. For more information, see https://loinc.org/. Additionally, if only positive results are reported, the lab must return an abnormal code. | |
ICPC Diagnoses | Specific conditions for specific indicators are identified in the NSW specifications document Aboriginal Health Program Key Performance Indicators: Data Specifications 2019/20-2021/22 Version 5.0 February 2021 |